These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 28314883
1. Stone former urine proteome demonstrates a cationic shift in protein distribution compared to normal. Kolbach-Mandel AM, Mandel NS, Hoffmann BR, Kleinman JG, Wesson JA. Urolithiasis; 2017 Aug; 45(4):337-346. PubMed ID: 28314883 [Abstract] [Full Text] [Related]
2. Selective protein enrichment in calcium oxalate stone matrix: a window to pathogenesis? Wesson JA, Kolbach-Mandel AM, Hoffmann BR, Davis C, Mandel NS. Urolithiasis; 2019 Dec; 47(6):521-532. PubMed ID: 30993355 [Abstract] [Full Text] [Related]
3. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein. Schwille PO, Schmiedl A, Manoharan M. Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561 [Abstract] [Full Text] [Related]
4. Comparison of cat and human calcium oxalate monohydrate kidney stone matrix proteomes. Wesson JA, Zenka R, Lulich J, Eisenhauer J, Davis C. Urolithiasis; 2022 Dec; 50(6):653-664. PubMed ID: 36180755 [Abstract] [Full Text] [Related]
5. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress. Asokan D, Kalaiselvi P, Varalakshmi P. Nephron Physiol; 2004 Dec; 97(1):p23-30. PubMed ID: 15153748 [Abstract] [Full Text] [Related]
6. Comparison of cat stone matrix and cat urine proteomes to human calcium oxalate stone matrix and urine proteomes. Wesson JA, Zenka R, Sherman K, Eisenhauer J, Lulich J, Davis C. Urolithiasis; 2024 Sep 13; 52(1):130. PubMed ID: 39271505 [Abstract] [Full Text] [Related]
7. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Borghi L, Meschi T, Guerra A, Bergamaschi E, Mutti A, Novarini A. Clin Chim Acta; 1995 Jul 31; 239(1):1-11. PubMed ID: 7586581 [Abstract] [Full Text] [Related]
8. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization. Kalaiselvi P, Udayapriya KL, Selvam R. BJU Int; 1999 Jun 31; 83(9):919-23. PubMed ID: 10368229 [Abstract] [Full Text] [Related]
9. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Gault MH, Chafe LL, Morgan JM, Parfrey PS, Harnett JD, Walsh EA, Prabhakaran VM, Dow D, Colpitts A. Medicine (Baltimore); 1991 Nov 31; 70(6):345-59. PubMed ID: 1956278 [Abstract] [Full Text] [Related]
10. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence]. Murayama T, Taguchi H. Hinyokika Kiyo; 1988 Sep 31; 34(9):1543-7. PubMed ID: 3213790 [Abstract] [Full Text] [Related]
11. Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers. Wesson JA, Ganne V, Beshensky AM, Kleinman JG. Urol Res; 2005 Jun 31; 33(3):206-12. PubMed ID: 15864572 [Abstract] [Full Text] [Related]
12. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group. Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027 [Abstract] [Full Text] [Related]
14. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers. Borghi L, Guerra A, Meschi T, Briganti A, Schianchi T, Allegri F, Novarini A. Kidney Int; 1999 Mar 07; 55(3):1041-50. PubMed ID: 10027942 [Abstract] [Full Text] [Related]
15. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, Nitsche S, Boistelle R, Berthézène P, Dupuy P, Vazi A, Berland Y, Dagorn JC, Verdier JM. Kidney Int; 1999 May 07; 55(5):1776-86. PubMed ID: 10231440 [Abstract] [Full Text] [Related]
17. Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct. Tiselius HG, Hallin A, Lindbäck B. Urol Res; 2001 Apr 07; 29(2):75-82. PubMed ID: 11396732 [Abstract] [Full Text] [Related]
18. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects. Robert M, Boularan AM, Delbos O, Guiter J, Descomps B. Urol Int; 1998 Apr 07; 60(1):41-6. PubMed ID: 9519420 [Abstract] [Full Text] [Related]
19. [Effects of urinary pH and acid-base balance on the formation of calcium oxalate stone]. Iida S. Nihon Hinyokika Gakkai Zasshi; 1991 Jan 07; 82(1):33-40. PubMed ID: 2046198 [Abstract] [Full Text] [Related]